Arix Bioscience PLC, a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, will be announcing its results for the six months ended June 30, 2023, and providing an update on the company's strategic review on September 27, 2023. The company will be hosting a virtual briefing for analysts at 9:00 am BST on the same day, and a live presentation and Q&A session for investors at 1:00 pm BST. The presentation is open to analysts and all existing and potential shareholders. Investors can sign up for free via the Investor Meet Company platform to attend the event. Arix Bioscience collaborates with exceptional entrepreneurs and provides capital, expertise, and networks to help accelerate their ideas into important new treatments for patients.